Number of participants withdrawing due to adverse events (AE) · scalp psoriasis
Steroid plus vitamin D leads to lower number of participants withdrawing due to adverse events compared with vitamin D (high certainty).
1 finding from 1 review
Grade 3 and 4 hematological adverse events (AE) ‐ anemia · non‐small cell lung cancer in the elderly population
It is very uncertain whether non‐platinum single‐agent changes grade 3 and 4 hematological adverse events (AE) ‐ anemia compared with non‐platinum combination treatment (very low certainty).
1 finding from 1 review
Intervention not reported
Incidence of adverse events ‐ isoniazid prophylaxis only · children with HIV infection aged 12 years and under
The intervention showed no clear difference in incidence of adverse events ‐ isoniazid prophylaxis only (moderate certainty).
1 finding from 1 review
Adverse events Adverse events due to study interventions · adults with chronic low‐back pain
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) reported adverse effects · patients with treating osteoarthritis
The intervention showed no clear difference in adverse events Participants (n) reported adverse effects (low certainty).
1 finding from 1 review
Serious adverse events: life‐threatening/ hospitalisation · adults with surgical wounds
1 finding from 1 review
Serious adverse events: life‐threatening/ hospitalisation · adults with surgical wounds
1 finding from 1 review
Serious adverse events: life‐threatening/ hospitalisation · adults with surgical wounds
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse events: life‐threatening/ hospitalisation · adults with surgical wounds
1 finding from 1 review
Serious adverse events: life‐threatening/ hospitalisation · adults with surgical wounds
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse events: life‐threatening/ hospitalisation · adults with surgical wounds
The review found no eligible studies for this question.
1 finding from 1 review
Participants with at least some Side Effects · community‐dwelling older adults ≥ 65 years of age
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Frequency of intervention‐related ocular adverse events ( · people with primary macula‐involving rhegmatogenous retinal detachments
1 finding from 1 review
Adverse events assessed in various ways, up to 24 months · people with neovascular glaucoma
1 finding from 1 review
no estimate extracted
6 participants
GRADE not reported
Participants with adverse events ‐ death Clinical criteria · healthy older adults aged ≥ 60 years
Recombinant zoster vaccine showed no clear difference in participants with adverse events ‐ deathClinical criteria compared with placebo (moderate certainty).
1 finding from 1 review
Non‐serious adverse events ‐ total number of participants · prevention and treatment of hepatic encephalopathy in people with cirrhosis
It is very uncertain whether summary of findings table ‐ Rifaximin changes non‐serious adverse events ‐ total number of participants compared with non‐absorbable disaccharide (very low certainty).
1 finding from 1 review
Non‐serious adverse events ‐ total number of participants · prevention and treatment of hepatic encephalopathy in people with cirrhosis
It is very uncertain whether summary of findings table ‐ Rifaximin plus non‐absorbable… changes non‐serious adverse events ‐ total number of participants compared with non‐absorbable disaccharides alone (very low certainty).
1 finding from 1 review
Non‐serious adverse events ‐ total number of particiapnts · prevention and treatment of hepatic encephalopathy in people with cirrhosis
It is very uncertain whether summary of findings table ‐ Rifaximin changes non‐serious adverse events ‐ total number of particiapnts compared with placebo/no intervention (very low certainty).
1 finding from 1 review
Number of any adverse events: immediately after treatment · overactive bladder
It is very uncertain whether summary of findings table ‐ Bladder training changes number of any adverse events: immediately after treatment compared with anticholinergics (very low certainty).
1 finding from 1 review
Number of any adverse events: immediately after treatment · overactive bladder
1 finding from 1 review